Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma.

Eitemau Tebyg

• Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma
  gan: Druce, M, et al.
  Cyhoeddwyd: (2012)
• Preliminary Report of the Use of Everolimus in a Patient with Progressive Medullary Thyroid Carcinoma
  gan: Druce, M, et al.
  Cyhoeddwyd: (2010)
• The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
  gan: Grozinsky-Glasberg, S, et al.
  Cyhoeddwyd: (2010)
• The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells
  gan: Grozinsky-Glasberg, S, et al.
  Cyhoeddwyd: (2009)
• IGF-1 influences Everolimus activity in medullary thyroid carcinoma
  gan: Erica eGentilin, et al.
  Cyhoeddwyd: (2015-05-01)